Cancer Clinical Pharmacology

Author:   Jan H. M. Schellens ,  Howard L. McLeod ,  David R. Newell
Publisher:   Oxford University Press
ISBN:  

9780192629661


Pages:   280
Publication Date:   05 May 2005
Format:   Hardback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $226.95 Quantity:  
Add to Cart

Share |

Cancer Clinical Pharmacology


Add your own review!

Overview

Cancer Clinical Pharmacology provides a comprehensive account of the scientific basis of anti-cancer therapy in patients with solid tumours and haematological malignancies. An international group of experts have brought together information on the basic principles of pharmacology and tumour biology, bioanalytical aspects, pharmacokinetics, and the pharmacodynamics of anti-cancer agents. The clinical pharmacology of individual anti-cancer agents are covered, including the most important recently registered novel anti-cancer drugs. This book will prove an invaluable source of information for all trainees in oncology, haematology and internal medicine. Since cancer clinical pharmacology is a vast subject this book will be useful for all individuals involved in cancer pharmacology such as nurses, pharmacists, general pharmacologists, and cancer scientists.

Full Product Details

Author:   Jan H. M. Schellens ,  Howard L. McLeod ,  David R. Newell
Publisher:   Oxford University Press
Imprint:   Oxford University Press
Dimensions:   Width: 19.50cm , Height: 2.00cm , Length: 25.40cm
Weight:   0.729kg
ISBN:  

9780192629661


ISBN 10:   0192629662
Pages:   280
Publication Date:   05 May 2005
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1. Bio-analytical methods for anticancer drugs; 2. Principles of pharmacokinetics; 3. Clinical implications and mechanisms of variability in the response to anticancer agents; 4. Drug development and study design; 5. Pyrimidine antimetabolites; 6. Purine analogs and antifolates; 7. Alkylating agents; 8. Epipodophyllotoxins; 9. Anthracyclines; 10. Taxanes; 11. Vinca alkaloids; 12. Topoisomerase I targeting agents; 13. Platinum agents; 14. Novel tyrosine kinase inhibitors: focus on Imatinib and Gefitinib; 15. Antiendoctrine drugs used in cancer treatment; 16. The clinical application of tumour biology

Reviews

This book clearly hits its mark. It is clear, reasonably complete, and very concise. Doody's<br>


This book clearly hits its mark. It is clear, reasonably complete, and very concise. Doody's


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

lgn

al

Shopping Cart
Your cart is empty
Shopping cart
Mailing List